Application of fecal hemoglobin–haptoglobin complex testing for small bowel lesions
- 13 March 2014
- journal article
- research article
- Published by Taylor & Francis Ltd in Scandinavian Journal of Gastroenterology
- Vol. 49 (5), 539-544
- https://doi.org/10.3109/00365521.2014.891260
Abstract
Objective. Fecal hemoglobin–haptoglobin (Hb–Hpt) complex testing is theoretically superior to immunochemical fecal occult blood test detecting human hemoglobin (Hb), as Hb–Hpt is more stable compared to Hb during passage through the gastrointestinal (GI) tract. The aim was to examine the role of fecal Hb–Hpt complex testing in predicting small bowel lesions detected by video capsule endoscopy (VCE). Materials and methods. Stools from patients undergoing small bowel VCE for obscure GI bleeding (OGIB) without ongoing overt bleeding were included. Two stool specimens were obtained on different days just before VCE to measure Hb–Hpt complex by ELISA and Hb by latex agglutination turbidimetric immunoassay. Results. Seventy-six patients (39 men and 37 women, average age 66 years) with suspected small bowel lesions entered. Median Hb–Hpt complex and Hb levels were significantly higher (p < 0.001) in those with small bowel lesions compared to those without. Using the suitable cutoff points (Hb >10 ng/ml and Hb–Hpt complex >5 ng/ml), the sensitivity and specificity of the Hb–Hpt complex test to predict small bowel lesions were 71.4% and 73.3%, and those of the Hb test were 61.2% and 89.3%. Small bowel lesions were found in 58.3% with only Hb–Hpt complex positive results (15.8% of total subjects) compared to 83.3% when both were positive (55.3% of total). Conclusions. Measuring fecal Hb–Hpt complex in addition to Hb may be useful to predict the presence of small bowel lesions in patients with OGIB.Keywords
This publication has 8 references indexed in Scilit:
- Patients With Colorectal Cancer Are Characterized by Increased Concentration of Fecal Hb-Hp Complex, Myeloperoxidase, and Secretory IgAAmerican Journal of Clinical Oncology, 2011
- Is It Worthwhile to Perform Capsule Endoscopy for Asymptomatic Patients with Positive Immunochemical Faecal Occult Blood Test?Digestive Diseases and Sciences, 2011
- Quantitative Immunochemical Fecal Occult Blood Testing for Colorectal Adenoma Detection: Evaluation in the Target Population of Screening and Comparison With Qualitative TestsAmerican Journal Of Gastroenterology, 2010
- Improved Diagnosis of Colorectal Cancer Using a Combination of Fecal Occult Blood and Novel Fecal Protein MarkersClinical Gastroenterology and Hepatology, 2008
- Random Comparison of Guaiac and Immunochemical Fecal Occult Blood Tests for Colorectal Cancer in a Screening PopulationGastroenterology, 2008
- Cochrane Systematic Review of Colorectal Cancer Screening Using the Fecal Occult Blood Test (Hemoccult): An UpdateThe American Journal of Gastroenterology, 2008
- Detection of colorectal neoplasms by the highly sensitive hemoglobin-haptoglobin complex in feces.International Journal of Colorectal Disease, 1999
- Occult Gastrointestinal BleedingThe New England Journal of Medicine, 1999